Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway

Progression-free survival shortens after each relapse in patients with follicular lymphoma treated in the rituximab era

(2017) A. Rivas-Delgado et al.   HEMATOLOGICAL ONCOLOGY

2016 US lymphoid malignancy statistics by World Health Organization subtypes

(2016) Lauren R. Teras et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

(2016) Laurie H Sehn et al.   LANCET ONCOLOGY

Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011

(2015) Mohammed Al-Hamadani et al.   AMERICAN JOURNAL OF HEMATOLOGY

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network

(2015) A Smith et al.   BRITISH JOURNAL OF CANCER

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

(2015) Carla Casulo et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years

(2015) Dlawer Abdulla Barzenje et al.   PLoS One

Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data

(2013) Nicholas R. Latimer   MEDICAL DECISION MAKING

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study

(2012) M. S. Czuczman et al.   BLOOD

Health-related quality of life (EQ-5D) among homeless persons compared to a general population sample in Stockholm County, 2006

(2012) Sun Sun et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma

(2011) Anne H. Blaes et al.   LEUKEMIA & LYMPHOMA